Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128484) titled 'Research on the Mechanism of Probiotics in Preventing Respiratory Infections in the Elderly' on July 21.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Wuxi people's Hospital
Condition:
Respiratory tract infection
Intervention:
Intervention group:The Probiotic A product (with specific ingredients including CCFM1279, CCFM1145, CCFM1127, root powder, dihydroquercetin, resistant dextrin, fructooligosaccharides, pineapple powder, micro-powder xylitol, elderberry juice powder, gold and silver pollen, and dandelion powder) is produced by Wuxi Pharmaceutical Technology Branch of Shanghai ...